Related Experiment Video

Updated: Jul 25, 2026

Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol
13:09

Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol

Published on: April 1, 2018

System for monitoring children with attention-deficit disorders

A G Goldman, D S Rich, L P Jeffrey

    American Journal of Hospital Pharmacy
    |December 1, 1982
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
    05:48

    The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

    Published on: June 12, 2020

    Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
    10:02

    Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)

    Published on: March 12, 2020

    Related Experiment Videos

    Last Updated: Jul 25, 2026

    Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol
    13:09

    Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol

    Published on: April 1, 2018

    The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
    05:48

    The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

    Published on: June 12, 2020

    Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
    10:02

    Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)

    Published on: March 12, 2020

    Related Concept Videos

    Attention-Deficit/Hyperactivity Disorder01:30

    Attention-Deficit/Hyperactivity Disorder

    Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
    Diagnostic Criteria and Symptoms
    To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.

    Articles linked to this work by shared authors, journal, and citation graph.

    The diagnosis of hypertension.

    Journal of clinical hypertension (Greenwich, Conn.)·2002

    Automated medication distribution systems and compliance with Joint Commission standards.

    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2002

    Effects of age, sex, race, diagnosis-related group, and hospital setting on lipid management in patients with coronary artery disease.

    The American journal of cardiology·2000

    A process for interpreting data on adverse drug events: determining optimal target levels.

    Clinical therapeutics·1999

    On accreditation of healthcare organizations. Determining eligibility for Accreditation of Home Pharmaceutical Services.

    Home care provider·1996

    Clozapine therapy for Parkinson's disease and other movement disorders.

    American journal of hospital pharmacy·1994

    Venlafaxine: a heterocyclic antidepressant.

    American journal of hospital pharmacy·1994

    Data Collection and Harmonization in Preterm Respiratory Research: Recommendations and Insights From PELICAN.

    Pediatric pulmonology·2026

    Evaluation of zinc status of critically ILL patients (infants and toddlers) admitted to pediatric intensive care units and its correlation to their outcome.

    QJM : monthly journal of the Association of Physicians·2026

    Procalcitonin as a biomarker of bacterial infection in children and adolescents with chronic liver disease.

    QJM : monthly journal of the Association of Physicians·2026

    Prevalence of chronic pain among U.S. children with neurodevelopmental disorders.

    Pain reports·2026

    Pediatric Bloodstream Infections in Eastern Democratic Republic of the Congo: Epidemiology, Antimicrobial Resistance Patterns, and Predictors of Mortality.

    Infection and drug resistance·2026

    Glycosylation disorders in pediatric epilepsy: pathophysiology, imaging and precision therapy.

    Frontiers in neurology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us